Ebola: experimental vaccine trial an 'unqualified success'
Early human tests suggest the drug is safe and may help immune systems fight Ebola, but more trials are needed

The first human trial of an experimental Ebola vaccine has delivered promising results, according to the US National Institute of Health (NIH).
"On safety and on the ability to produce an appropriate immune response we can call this trial an unqualified success," Dr Anthony Fauci of the NIH told the BBC.
However, he stressed that this was only the early part of the first phase of the trial and much more testing was required to establish the vaccine's long-term safety and efficacy.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
There is currently no vaccine or cure for Ebola and the unprecedented scale of the current outbreak in West Africa has prompted pharmaceutical companies and health organisations to fast track the development of safe and effective treatments.
The vaccine has been jointly produced by the NIH and the British pharmaceutical company GlaxoSmithKline (GSK) and is one of three currently in development.
In the first phase of the trial, all 20 American volunteers who received the vaccine developed antibodies to the virus and none suffered any major side effects. However, some patients did develop a fever in response to the drug, but it "resolved within one day", according to scientists.
GSK has reportedly made a request for an indemnity agreement to protect itself against unforeseen side effects that could develop in the future.
"It's important to remember that these data are the first piece in the jigsaw and we're continuing to gather other important information," Dr Moncef Slaoui, chairman of global vaccines at GSK told The Guardian.
If the results of the following phases of the trial are positive, thousands of volunteers, including healthcare workers, will receive the vaccine in West Africa in early 2015, he said.
Almost 5,700 people are known to have died from the disease and almost 15,000 have been infected across the region, though actual figures are believed to be much higher.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Today's political cartoons - March 29, 2025
Cartoons Saturday's cartoons - my way or Norway, running orders, and more
By The Week US Published
-
5 tactically sound cartoons about the leaked Signal chat
Cartoons Artists take on the clown signal, baby steps, and more
By The Week US Published
-
Roast lamb shoulder with ginger and fresh turmeric recipe
The Week Recommends Succulent and tender and falls off the bone with ease
By The Week UK Published
-
'Like a sound from hell': Serbia and sonic weapons
The Explainer Half a million people sign petition alleging Serbian police used an illegal 'sound cannon' to disrupt anti-government protests
By Abby Wilson Published
-
The arrest of the Philippines' former president leaves the country's drug war in disarray
In the Spotlight Rodrigo Duterte was arrested by the ICC earlier this month
By Justin Klawans, The Week US Published
-
Ukrainian election: who could replace Zelenskyy?
The Explainer Donald Trump's 'dictator' jibe raises pressure on Ukraine to the polls while the country is under martial law
By Sorcha Bradley, The Week UK Published
-
Why Serbian protesters set off smoke bombs in parliament
THE EXPLAINER Ongoing anti-corruption protests erupted into full view this week as Serbian protesters threw the country's legislature into chaos
By Rafi Schwartz, The Week US Published
-
Who is the Hat Man? 'Shadow people' and sleep paralysis
In Depth 'Sleep demons' have plagued our dreams throughout the centuries, but the explanation could be medical
By The Week Staff Published
-
Why Assad fell so fast
The Explainer The newly liberated Syria is in an incredibly precarious position, but it's too soon to succumb to defeatist gloom
By The Week UK Published
-
Romania's election rerun
The Explainer Shock result of presidential election has been annulled following allegations of Russian interference
By Sorcha Bradley, The Week UK Published
-
Russia's shadow war in Europe
Talking Point Steering clear of open conflict, Moscow is slowly ratcheting up the pressure on Nato rivals to see what it can get away with.
By The Week UK Published